CAMBIA (Nautilus Neurosciences, Inc.)
Welcome to the PulseAid listing for the CAMBIA drug offered from Nautilus Neurosciences, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Nautilus Neurosciences, Inc. |
| NON-PROPRIETARY NAME: | Diclofenac Potassium |
| SUBSTANCE NAME: | DICLOFENAC POTASSIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-04-20 |
| END MARKETING DATE: | 0000-00-00 |
CAMBIA HUMAN PRESCRIPTION DRUG Details:
| Item Description | CAMBIA from Nautilus Neurosciences, Inc. |
| LABELER NAME: | Nautilus Neurosciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mg) |
| START MARKETING DATE: | 2010-04-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50192-113_3a38ddb1-2e6b-406e-8992-a1c9cbd9acd0 |
| PRODUCT NDC: | 50192-113 |
| APPLICATION NUMBER: | NDA022165 |
Other DICLOFENAC POTASSIUM Pharmaceutical Manufacturers / Labelers:
